Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 126

1.

Targeted radiotherapy for early breast cancer - Authors' reply.

Coles CE, Haviland JS, Kirby AM, Titley J, Wilcox M, Bliss JM, Yarnold JR.

Lancet. 2018 Jan 6;391(10115):27-28. doi: 10.1016/S0140-6736(17)33317-2. No abstract available.

PMID:
29323651
2.

Late normal tissue effects in the arm and shoulder following lymphatic radiotherapy: Results from the UK START (Standardisation of Breast Radiotherapy) trials.

Haviland JS, Mannino M, Griffin C, Porta N, Sydenham M, Bliss JM, Yarnold JR; START Trialists' Group.

Radiother Oncol. 2018 Jan;126(1):155-162. doi: 10.1016/j.radonc.2017.10.033. Epub 2017 Nov 15.

3.

Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial.

Coles CE, Griffin CL, Kirby AM, Titley J, Agrawal RK, Alhasso A, Bhattacharya IS, Brunt AM, Ciurlionis L, Chan C, Donovan EM, Emson MA, Harnett AN, Haviland JS, Hopwood P, Jefford ML, Kaggwa R, Sawyer EJ, Syndikus I, Tsang YM, Wheatley DA, Wilcox M, Yarnold JR, Bliss JM; IMPORT Trialists.

Lancet. 2017 Sep 9;390(10099):1048-1060. doi: 10.1016/S0140-6736(17)31145-5. Epub 2017 Aug 2.

4.

The UK HeartSpare Study (Stage II): Multicentre Evaluation of a Voluntary Breath-hold Technique in Patients Receiving Breast Radiotherapy.

Bartlett FR, Donovan EM, McNair HA, Corsini LA, Colgan RM, Evans PM, Maynard L, Griffin C, Haviland JS, Yarnold JR, Kirby AM.

Clin Oncol (R Coll Radiol). 2017 Mar;29(3):e51-e56. doi: 10.1016/j.clon.2016.11.005. Epub 2016 Nov 24.

PMID:
27890346
5.

Prolongation of overall treatment time as a cause of treatment failure in early breast cancer: An analysis of the UK START (Standardisation of Breast Radiotherapy) trials of radiotherapy fractionation.

Haviland JS, Bentzen SM, Bliss JM, Yarnold JR; START Trial Management Group.

Radiother Oncol. 2016 Dec;121(3):420-423. doi: 10.1016/j.radonc.2016.08.027. Epub 2016 Sep 22.

6.

Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5456 breast and prostate cancer patients.

Andreassen CN, Rosenstein BS, Kerns SL, Ostrer H, De Ruysscher D, Cesaretti JA, Barnett GC, Dunning AM, Dorling L, West CML, Burnet NG, Elliott R, Coles C, Hall E, Fachal L, Vega A, Gómez-Caamaño A, Talbot CJ, Symonds RP, De Ruyck K, Thierens H, Ost P, Chang-Claude J, Seibold P, Popanda O, Overgaard M, Dearnaley D, Sydes MR, Azria D, Koch CA, Parliament M, Blackshaw M, Sia M, Fuentes-Raspall MJ, Ramon Y Cajal T, Barnadas A, Vesprini D, Gutiérrez-Enríquez S, Mollà M, Díez O, Yarnold JR, Overgaard J, Bentzen SM, Alsner J; International Radiogenomics Consortium (RgC).

Radiother Oncol. 2016 Dec;121(3):431-439. doi: 10.1016/j.radonc.2016.06.017. Epub 2016 Jul 18.

7.

Do Patient-reported Outcome Measures Agree with Clinical and Photographic Assessments of Normal Tissue Effects after Breast Radiotherapy? The Experience of the Standardisation of Breast Radiotherapy (START) Trials in Early Breast Cancer.

Haviland JS, Hopwood P, Mills J, Sydenham M, Bliss JM, Yarnold JR; START Trialists' Group.

Clin Oncol (R Coll Radiol). 2016 Jun;28(6):345-53. doi: 10.1016/j.clon.2016.01.011. Epub 2016 Feb 8.

8.

Accelerated partial breast irradiation: the new standard?

Coles CE, Yarnold JR.

Lancet. 2016 Jan 16;387(10015):201-2. doi: 10.1016/S0140-6736(15)00518-8. Epub 2015 Oct 19. No abstract available.

PMID:
26494414
9.

Clinical impact of IMPORT HIGH trial (CRUK/06/003) on breast radiotherapy practices in the United Kingdom.

Tsang Y, Ciurlionis L, Kirby AM, Locke I, Venables K, Yarnold JR, Titley J, Bliss J, Coles CE; IMPORT Trial Management Group.

Br J Radiol. 2015;88(1056):20150453. doi: 10.1259/bjr.20150453. Epub 2015 Oct 22.

10.

The UK HeartSpare Study (Stage IB): randomised comparison of a voluntary breath-hold technique and prone radiotherapy after breast conserving surgery.

Bartlett FR, Colgan RM, Donovan EM, McNair HA, Carr K, Evans PM, Griffin C, Locke I, Haviland JS, Yarnold JR, Kirby AM.

Radiother Oncol. 2015 Jan;114(1):66-72. doi: 10.1016/j.radonc.2014.11.018. Epub 2014 Nov 26.

PMID:
25739317
11.

A multicentre observational study evaluating image-guided radiotherapy for more accurate partial-breast intensity-modulated radiotherapy: comparison with standard imaging technique.

Harris EJ, Mukesh M, Jena R, Baker A, Bartelink H, Brooks C, Dean J, Donovan EM, Collette S, Eagle S, Fenwick JD, Graham PH, Haviland JS, Kirby AM, Mayles H, Mitchell RA, Perry R, Poortmans P, Poynter A, Shentall G, Titley J, Thompson A, Yarnold JR, Coles CE, Evans PM; on behalf of the IMPORT Trials Management Group.

Southampton (UK): NIHR Journals Library; 2014 Nov.

12.

Voluntary breath-hold technique for reducing heart dose in left breast radiotherapy.

Bartlett FR, Colgan RM, Donovan EM, Carr K, Landeg S, Clements N, McNair HA, Locke I, Evans PM, Haviland JS, Yarnold JR, Kirby AM.

J Vis Exp. 2014 Jul 3;(89). doi: 10.3791/51578.

13.

Cytokine levels as biomarkers of radiation fibrosis in patients treated with breast radiotherapy.

Westbury CB, Haviland J, Davies S, Gothard L, Abdi BA, Sydenham M, Bowen J, Stratton R, Short SC, Yarnold JR.

Radiat Oncol. 2014 Apr 30;9:103. doi: 10.1186/1748-717X-9-103.

14.

Late effects of breast radiotherapy.

Haviland JS, Bliss JM, Sydenham M, Yarnold JR.

Lancet. 2014 Apr 19;383(9926):1383-4. doi: 10.1016/S0140-6736(14)60681-4. No abstract available.

PMID:
24759249
15.

Changes in mast cell number and stem cell factor expression in human skin after radiotherapy for breast cancer.

Westbury CB, Freeman A, Rashid M, Pearson A, Yarnold JR, Short SC.

Radiother Oncol. 2014 May;111(2):206-11. doi: 10.1016/j.radonc.2014.02.020. Epub 2014 Apr 17.

PMID:
24746564
16.

Response to D. Woolf and M. Keshtgar's reply to: breast radiotherapy and heart disease - where are we now?

Bartlett FR, Yarnold JR, Kirby AM.

Clin Oncol (R Coll Radiol). 2014 Feb;26(2):123. doi: 10.1016/j.clon.2013.11.005. Epub 2013 Dec 2. No abstract available.

PMID:
24296327
17.

Multileaf collimation cardiac shielding in breast radiotherapy: Cardiac doses are reduced, but at what cost?

Bartlett FR, Yarnold JR, Donovan EM, Evans PM, Locke I, Kirby AM.

Clin Oncol (R Coll Radiol). 2013 Dec;25(12):690-6. doi: 10.1016/j.clon.2013.09.002. Epub 2013 Sep 29.

PMID:
24083961
18.

The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials.

Haviland JS, Owen JR, Dewar JA, Agrawal RK, Barrett J, Barrett-Lee PJ, Dobbs HJ, Hopwood P, Lawton PA, Magee BJ, Mills J, Simmons S, Sydenham MA, Venables K, Bliss JM, Yarnold JR; START Trialists' Group.

Lancet Oncol. 2013 Oct;14(11):1086-1094. doi: 10.1016/S1470-2045(13)70386-3. Epub 2013 Sep 19.

PMID:
24055415
19.

Breast radiotherapy and heart disease - where are we now?

Bartlett FR, Yarnold JR, Kirby AM.

Clin Oncol (R Coll Radiol). 2013 Dec;25(12):687-9. doi: 10.1016/j.clon.2013.08.001. Epub 2013 Aug 24. No abstract available.

PMID:
23981777
20.

The UK HeartSpare Study: randomised evaluation of voluntary deep-inspiratory breath-hold in women undergoing breast radiotherapy.

Bartlett FR, Colgan RM, Carr K, Donovan EM, McNair HA, Locke I, Evans PM, Haviland JS, Yarnold JR, Kirby AM.

Radiother Oncol. 2013 Aug;108(2):242-7. doi: 10.1016/j.radonc.2013.04.021. Epub 2013 May 29.

PMID:
23726115

Supplemental Content

Loading ...
Support Center